Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Healthtrust
Express Scripts
QuintilesIMS
McKinsey
Colorcon
Johnson and Johnson
Merck
Daiichi Sankyo

Generated: May 23, 2018

DrugPatentWatch Database Preview

Claims for Patent: 5,674,872

« Back to Dashboard

Summary for Patent: 5,674,872
Title: Treatment of ovarian cancer
Abstract:A method of treating ovarian cancer in a human afflicted therewith which comprises administering to such human an effective amount of a compound of the water soluble camptothecin analog class.
Inventor(s): Johnson; Randall Keith (Ardmore, PA)
Assignee: SmithKline Beecham Corporation (Philadelphia, PA)
Application Number:08/411,056
Patent Claims: 1. A method of treating ovarian cancer in a human afflicted therewith which comprises administering to such human an effective amount of a compound of the formula: ##STR3## wherein: a) X is hydroxy and R is trimethylammoniummethyl;

b) X is hydroxy and R is N-methylpiperazinylmethyl;

c) X is hydroxy and R is N-methylanilinomethyl;

d) X is hydroxy and R is cyclohexylaminomethyl;

e) X is hydroxy and R is N,N-dimethylaminoethyloxymethyl;

f) X is hydroxy and R is cyclopropylaminomethyl;

g) X is hydroxy and R is morpholinomethyl;

h) X is hydroxy and R is aminomethyl;

i) X is hydroxy and R is cyanomethyl; or

j) X is hydroxy and R is dimethylaminomethyl

or any pharmaceutically acceptable salts, hydrates and solyates thereof; wherein the course of therapy employed is from about 1.0 to about 2.5 mg/m.sup.2 of body surface area per day for about five consecutive days.

2. The method of claim 1 wherein the administration is oral.

3. The method of claim 1 wherein the administration is parenteral.

4. The method of claim 3 wherein the course of therapy employed is from about 1.5 to about 2 mg/m.sup.2 of body surface area per day for about five consecutive days.

5. The method of claim 4 wherein the course of therapy is repeated at least once at about a seven day to about a twenty-eight day interval.

6. The method of claim 3 wherein the administration is via short or long intravenous infusion.

7. The method of claim 6 wherein the administration is via a 30 minute intravenous infusion.

8. The method of claim 6 wherein the administration is via a 24 hour intravenous infusion.

9. The method of claim 6 wherein the compound is topotecan.

10. The method of claim 1 wherein the compound is topotecan.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
QuintilesIMS
Fuji
Dow
Colorcon
Harvard Business School
US Army
Julphar
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.